Campbell & Co Investment Adviser’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,540
Closed -$479K 1078
2024
Q3
$479K Buy
4,540
+1,301
+40% +$133K 0.04% 738
2024
Q2
$302K Buy
+3,239
New +$344K 0.03% 826
2023
Q3
Sell
-5,370
Closed -$504K 958
2023
Q2
$504K Sell
5,370
-5,547
-51% -$443K 0.09% 434
2023
Q1
$742K Buy
10,917
+2,803
+35% +$227K 0.14% 270
2022
Q4
$577K Sell
8,114
-1,391
-15% -$94.8K 0.14% 246
2022
Q3
$590K Buy
9,505
+4,428
+87% +$319K 0.13% 267
2022
Q2
$339K Sell
5,077
-127
-2% -$9.54K 0.09% 411
2022
Q1
$374K Buy
5,204
+1,704
+49% +$140K 0.1% 386
2021
Q4
$335K Sell
3,500
-1,800
-34% -$122K 0.11% 318
2021
Q3
$259K Sell
5,300
-600
-10% -$30.2K 0.08% 420
2021
Q2
$297K Sell
5,900
-1,200
-17% -$59K 0.12% 327
2021
Q1
$278K Buy
+7,100
New +$276K 0.17% 250

Other funds holding BXC

Campbell & Co Investment Adviser's BXC Position: Q4 2024 in Review

Campbell & Co Investment Adviser sold out of BlueLinx (BXC) in Q4 2024, closing a stake of 4,540 shares — an estimated $479K sold.

Campbell & Co Investment Adviser first reported a position in BXC in Q1 2021 and held it in 12 quarters. The position peaked at $742K in Q1 2023. 175 funds tracked by Wall St. Rank hold BXC as of Q4 2024.

  • Campbell & Co Investment Adviser reported no remaining BlueLinx position as of Q4 2024 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 4,540 BlueLinx shares in Q4 2024, an estimated $479K.
  • Campbell & Co Investment Adviser first reported a position in BlueLinx in Q1 2021 and held it in 12 quarters.
  • Campbell & Co Investment Adviser's BlueLinx position peaked at $742K in Q1 2023.
  • 175 funds tracked by Wall St. Rank held BlueLinx as of Q4 2024.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2024, filed 10 Feb 2025.